The most promising human study is ACT's. It is two years into clinical trials using stem cells derived from human embryos to treat two forms of blindness, including macular degeneration, with encouraging results. One patient's vision went from 20/400 to 20/40, said Lanza.
Dr. Lanza has done it, see you boys and girls at $1.00+ in coming days when the results from the patient cohort inejected with 150,000 cells are announced.)
At some point this has to go higher...The science works, they just need to get the word out...For legal reasons, they need to stay conservative in any statements made by the company...Wait until the day they can unload the news.